6 Results for "

N-Butyrylglycine-13C2,15N

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "N-Butyrylglycine-13C2,15N" in MCE Product Catalog:

Art. -Nr.: HY-W754052
N-Butyrylglycine- 13C2, 15N is the 13C- and 15N-labeled N-Butyrylglycine (HY-113119). N-Butyrylglycine is a Glycine (HY-Y0966) derivative .
Art. -Nr.: HY-105183
CAS. Nr.: 153049-49-1
Target:  

Endothelin Receptor

Forschungsgebiete:  

Others

PD 145065 is a highly potent but non-selective endothelin receptor antagonist with an IC50 value of 4 nM for the ETA receptor for rabbit renal artery vascular smooth muscle cells .
Art. -Nr.: HY-P0206S1
RPP-(Gly-1 13C2, 15N)-FSPFR TFA is 13C- and 15N-labeled Bradykinin (HY-P0206). Bradykinin is an effective endothelium-dependent vasodilator that can lower blood pressure. Bradykinin can induce contraction of bronchial and intestinal non-vascular smooth muscle, increase vascular permeability, and participate in the mechanism of pain .
Art. -Nr.: HY-159193S
Forschungsgebiete:  

Others

DHATS(Leu- 13C6, 15N)PVTIPSAVST(Gly- 13C2, 15N)HTTPLPVTDT (TFA) is the 13C and 15N labeled isotope of DHATS-PVTIPSAVST-HTTPLPVTDT (TFA) .
Art. -Nr.: HY-P3448S1
Synonyms: CEND-1-13C2,15N; iRGD-13C2,15N; LSTA1-13C2,15N
Forschungsgebiete:  

Cancer

Certepetide- 13C2, 15N (CEND-1- 13C2, 15N) is the 13C- and 15N-labeled Certepetide (HY-P3448). Certepetide (CEND-1) is a bifunctional cyclic peptide (a.k.a. iRGD). Certepetide is a tumor-penetrating enhancer via RGD motif interaction with alphav-integrins and via activating NRP-1, and transforms the solid tumor microenvironment into a temporary agent conduit. Certepetide accumulates in tumors, and is used in the research of pancreatic cancer and other solid tumors .
Art. -Nr.: HY-P11344S
Forschungsgebiete:  

Others

LLIYFASQSISGIPDR- 13C2, 15N is the 13C- and 15N-labeled LLIYFASQSISGIPDR.